Lysodren União Europeia - polonês - EMA (European Medicines Agency)

lysodren

hra pharma rare diseases - mitotan - nowotwory kory nadnerczy - Środki przeciwnowotworowe - objawowe leczenie zaawansowanego (nieoperacyjnego, przerzutowego lub nawrotowego) raka kory nadnerczy. efekt lysodren na нефункциональности kory nadnerczy nowotwór nie jest zainstalowany.

Libmeldy União Europeia - polonês - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - inne leki na układ nerwowy - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Elfabrio União Europeia - polonês - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - inne przewodu pokarmowego i przemianę materii narzędzia, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Neurobion Advance 100 mg + 50 mg + 1 mg Tabletki powlekane Polônia - polonês - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

neurobion advance 100 mg + 50 mg + 1 mg tabletki powlekane

p&g health germany gmbh - thiamini nitras + pyridoxini hydrochloridum + cyanocobalaminum - tabletki powlekane - 100 mg + 50 mg + 1 mg